MIND HEALTH AI LIMITED


Director	MCLAUGHLAN, David Charles, Dr


Registered Address	29 Trelawn Road
	London
	SW2 1DH


Registered Number	13064306 (England and Wales)

Balance Sheet as at
30 September 2026

	30 Sep 2026 £	31 Dec 2025 £


Current Assets	174,189	5,620
Creditors amounts falling due within one year	(887)	(7,206)
Net current assets (liabilities)	173,302	(1,586)

Total assets less current liabilities	173,302	(1,586)

Accruals and deferred income	(1,460)	-
Net assets (liabilities)	171,842	(1,586)
Capital and reserves	171,842	(1,586)

The company is a private company limited by shares and registered in England and Wales. It was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The Director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Average number of employees
The average number of persons employed by the company in the period was 1 (previous period: 1).
Additional Disclosures
The financial statements have been prepared in accordance with FRS 105, the Financial Reporting Standard applicable to the Micro-entities Regime, on a basis other than going concern. During the period, the company disposed of its business and associated assets for consideration of £220,000. Trading activities ceased on 30 September 2026, and the director intends to place the company into a Members' Voluntary Liquidation, with the remaining net assets to be distributed to shareholders following settlement of the company's liabilities. Accordingly, the director considers that the going concern basis of accounting is no longer appropriate. The financial statements have therefore been prepared on a non-going-concern basis, with assets and liabilities reviewed to reflect their expected recoverable and settlement amounts. Liabilities relating to trading activities up to 30 September 2026 have been recognised in the period, including amounts settled after the reporting date.

The financial statements were approved and authorised for issue by the Director on 27 October 2026, and are signed on its behalf by:

MCLAUGHLAN, David Charles, Dr
Director
Registered Company No. 13064306